StonvexLoading…
StonvexStonvexStonvexCore line items from BEKE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $13.52B | $12.80B | $10.95B | $8.80B |
Operating Income | $301.85M | $515.80M | $675.65M | $-120.76M |
Net Income | $428.13M | $556.89M | $828.64M | $-200.96M |
EPS (Diluted) | $0.12 | $0.16 | $0.23 | $-0.06 |
Total Assets | $16.68B | $18.24B | $16.95B | $15.85B |
Total Liabilities | $7.17B | $8.45B | $6.78B | $5.84B |
Cash & Equivalents | $1.11B | $1.64B | $2.69B | $2.73B |
Free Cash Flow OCF − CapEx | $-140.70M | $1.15B | $1.45B | $1.11B |
Shares Outstanding | 3.47B | 3.54B | 3.61B | 3.57B |